Several cross-sectional epidemiologic studies consistently showed that circulating PRL levels positive correlated with increased insulin sensitivity, lower glucose and lipid levels, and lower prevalence of T2D and metabolic syndrome (14, 15). The gene discussed is INS; the disease is metabolic syndrome.